Arvinas (ARVN) Return on Equity [ROE] (2019 - 2026)
Arvinas' Return on Equity [ROE] came in at -1.77% for Q3 2026, up 8.20 percentage points from -9.97% a year earlier but down 3.73 percentage points from the prior quarter.
Arvinas (ARVN) Return on Equity [ROE] (2019 - 2026) Analysis & Trends
For FY2025, Arvinas' Return on Equity [ROE] was -16.23%, up 16.33 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of +10.29 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was -32.56% in FY2024 (+27.00 pp), -59.56% in FY2023 (-19.18 pp), -40.38% in FY2022 (-14.52 pp) and -25.86% in FY2021 (+0.66 pp).
- The five-year range for quarterly Return on Equity [ROE] is -65.31% (Q4 2023) to 1.96% (Q2 2026).
- Year-over-year, Return on Equity [ROE] increased in seven of the last eight quarters, with an average year-over-year change of +19.57 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q1 2025 (a gain of 48.04 percentage points), and the weakest in Q1 2026 (a drop of 46.30 percentage points).
- Business Quant data shows ARVN's Return on Equity [ROE] at 1.96% (Q2 2026), -53.93% (Q1 2026) and -16.19% (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Arvinas | 453.26 Mn | -1.97 Bn | 400,000.00 | -2.27% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -2.27% |
| Jun 30, 2026 | 1.66% |
| Mar 31, 2026 | -54.39% |
| Dec 31, 2025 | -16.15% |
| Sep 30, 2025 | -10.43% |
| Jun 30, 2025 | -10.68% |
| Mar 31, 2025 | -6.66% |
| Dec 31, 2024 | -33.95% |
| Sep 30, 2024 | -49.79% |
| Jun 30, 2024 | -52.07% |
| Mar 31, 2024 | -54.60% |
| Dec 31, 2023 | -62.87% |
| Sep 30, 2023 | -60.75% |
| Jun 30, 2023 | -59.04% |
| Mar 31, 2023 | -54.80% |
| Dec 31, 2022 | -50.07% |
| Sep 30, 2022 | 21,546,255.55% |
| Jun 30, 2022 | 13,243,367.96% |
| Mar 31, 2022 | 5,554,780.90% |
| Dec 31, 2021 | 5,226,930.35% |
Arvinas Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ARVN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ARVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ARVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();